-
1
-
-
0026354053
-
Ventricular enlargement and remodeling following acute myocardial infarction: Mechanisms and management
-
Braunwald E, Pfeffer MA. Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. Am J Cardiol 1991;68:1D-6D.
-
(1991)
Am J Cardiol
, vol.68
-
-
Braunwald, E.1
Pfeffer, M.A.2
-
2
-
-
0033939770
-
Postinfarction left ventricular remodeling: A pathophysiological and therapeutic review
-
Yousef ZR, Redwood SR, Marber MS. Postinfarction left ventricular remodeling: a pathophysiological and therapeutic review. Cardiovasc Drugs Ther. 2000;14:243-252.
-
(2000)
Cardiovasc Drugs Ther
, vol.14
, pp. 243-252
-
-
Yousef, Z.R.1
Redwood, S.R.2
Marber, M.S.3
-
3
-
-
0023707490
-
Cellular mechanisms of myocardial infarct expansion
-
Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation. 1988;78:186-201.
-
(1988)
Circulation
, vol.78
, pp. 186-201
-
-
Weisman, H.F.1
Bush, D.E.2
Mannisi, J.A.3
Weisfeldt, M.L.4
Healy, B.5
-
4
-
-
0026695294
-
The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
-
Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
-
(1992)
J Am Coll Cardiol
, vol.20
, pp. 248-254
-
-
Packer, M.1
-
5
-
-
0347987900
-
Norepinephrine induces apoptosis in neonatal rat endothelial cells via down-regulation of Bcl-2 and activation of beta-adrenergic and caspase-2 pathways
-
Fu YC, Chi CS, Yin SC, Hwang B, Chiu YT, Hsu SL. Norepinephrine induces apoptosis in neonatal rat endothelial cells via down-regulation of Bcl-2 and activation of beta-adrenergic and caspase-2 pathways. Cardiovasc Res. 2004;61:143-151.
-
(2004)
Cardiovasc Res
, vol.61
, pp. 143-151
-
-
Fu, Y.C.1
Chi, C.S.2
Yin, S.C.3
Hwang, B.4
Chiu, Y.T.5
Hsu, S.L.6
-
6
-
-
14944362972
-
Healing after myocardial infarction
-
Ertl G, Frantz S. Healing after myocardial infarction. Cardiovasc Res. 2005;66:22-32.
-
(2005)
Cardiovasc Res
, vol.66
, pp. 22-32
-
-
Ertl, G.1
Frantz, S.2
-
7
-
-
0022536391
-
Left ventricular remodeling after myocardial infarction: A corollary to infarct expansion
-
McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S, Alderman JD, Ferguson JJ, Safian RD, Grossman W. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74:693-702.
-
(1986)
Circulation
, vol.74
, pp. 693-702
-
-
McKay, R.G.1
Pfeffer, M.A.2
Pasternak, R.C.3
Markis, J.E.4
Come, P.C.5
Nakao, S.6
Alderman, J.D.7
Ferguson, J.J.8
Safian, R.D.9
Grossman, W.10
-
9
-
-
0023219810
-
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction
-
White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
-
(1987)
Circulation
, vol.76
, pp. 44-51
-
-
White, H.D.1
Norris, R.M.2
Brown, M.A.3
Brandt, P.W.4
Whitlock, R.M.5
Wild, C.J.6
-
10
-
-
0034975055
-
Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: Their inter-relation and prognostic impact
-
Gaudron P, Kugler I, Hu K, Bauer W, Eilles C, Ertl G. Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. J Am Coll Cardiol. 2001;38:33-40.
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 33-40
-
-
Gaudron, P.1
Kugler, I.2
Hu, K.3
Bauer, W.4
Eilles, C.5
Ertl, G.6
-
11
-
-
33746829275
-
Transforming growth factor-betas and vascular disorders
-
Bobik A. Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol. 2006;26:1712-1720.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 1712-1720
-
-
Bobik, A.1
-
12
-
-
35048875855
-
TGF-beta signaling: A tale of two responses
-
Rahimi RA, Leof EB. TGF-beta signaling: a tale of two responses. J Cell Biochem. 2007;102:593-608.
-
(2007)
J Cell Biochem
, vol.102
, pp. 593-608
-
-
Rahimi, R.A.1
Leof, E.B.2
-
13
-
-
0028932732
-
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
-
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group
-
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
-
(1995)
Lancet
, vol.345
, pp. 669-685
-
-
-
14
-
-
1642494797
-
Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: The CAPRICORN Echo Substudy
-
Doughty RN, Whalley GA, Walsh HA, Gamble GD, Lopez-Sendon J, Sharpe N. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation. 2004;109:201-206.
-
(2004)
Circulation
, vol.109
, pp. 201-206
-
-
Doughty, R.N.1
Whalley, G.A.2
Walsh, H.A.3
Gamble, G.D.4
Lopez-Sendon, J.5
Sharpe, N.6
-
15
-
-
0035810547
-
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
-
Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385-1390.
-
(2001)
Lancet
, vol.357
, pp. 1385-1390
-
-
Dargie, H.J.1
-
16
-
-
0027499036
-
Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors
-
Borghi C, Boschi S, Ambrosioni E, Melandri G, Branzi A, Magnani B. Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol. 1993;33:40-45.
-
(1993)
J Clin Pharmacol
, vol.33
, pp. 40-45
-
-
Borghi, C.1
Boschi, S.2
Ambrosioni, E.3
Melandri, G.4
Branzi, A.5
Magnani, B.6
-
17
-
-
0019508224
-
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure
-
Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981;63:645-651.
-
(1981)
Circulation
, vol.63
, pp. 645-651
-
-
Dzau, V.J.1
Colucci, W.S.2
Hollenberg, N.K.3
Williams, G.H.4
-
18
-
-
23944446113
-
Early time to benefit with intensive statin treatment: Could it be the pleiotropic effects?
-
Ray KK, Cannon CP. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects? Am J Cardiol 2005;96:54F-60F.
-
(2005)
Am J Cardiol
, vol.96
-
-
Ray, K.K.1
Cannon, C.P.2
-
19
-
-
26844447541
-
22 Investigators. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: Results from the PROVE IT-TIMI 22 trial
-
Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E; PROVE IT-TIMI 22 Investigators. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2005;46:1405-1410.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1405-1410
-
-
Ray, K.K.1
Cannon, C.P.2
McCabe, C.H.3
Cairns, R.4
Tonkin, A.M.5
Sacks, F.M.6
Jackson, G.7
Braunwald, E.8
-
20
-
-
85047679265
-
Postreperfusion inflammation: A model for reaction to injury in cardiovascular disease
-
Entman ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res. 1994;28:1301-1311.
-
(1994)
Cardiovasc Res
, vol.28
, pp. 1301-1311
-
-
Entman, M.L.1
Smith, C.W.2
-
21
-
-
13044267739
-
Cytokines and the microcirculation in ischemia and reperfusion
-
Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, Michael LH, Ballantyne CM, Smith CW, Entman ML. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol. 1998;30:2567-2576.
-
(1998)
J Mol Cell Cardiol
, vol.30
, pp. 2567-2576
-
-
Frangogiannis, N.G.1
Youker, K.A.2
Rossen, R.D.3
Gwechenberger, M.4
Lindsey, M.H.5
Mendoza, L.H.6
Michael, L.H.7
Ballantyne, C.M.8
Smith, C.W.9
Entman, M.L.10
-
22
-
-
0028231065
-
Adhesion molecules and inflammatory injury
-
Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. Faseb J. 1994;8:504-512.
-
(1994)
Faseb J
, vol.8
, pp. 504-512
-
-
Albelda, S.M.1
Smith, C.W.2
Ward, P.A.3
-
23
-
-
1842329163
-
Mechanisms of neutrophil-induced parenchymal cell injury
-
Jaeschke H, Smith CW. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol. 1997;61:647-653.
-
(1997)
J Leukoc Biol
, vol.61
, pp. 647-653
-
-
Jaeschke, H.1
Smith, C.W.2
-
24
-
-
0034683031
-
Status of myocardial antioxidants in ischemia-reperfusion injury
-
Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res. 2000;47:446-456.
-
(2000)
Cardiovasc Res
, vol.47
, pp. 446-456
-
-
Dhalla, N.S.1
Elmoselhi, A.B.2
Hata, T.3
Makino, N.4
-
25
-
-
33748645920
-
Acute myocardial infarction and heart failure: Role of apoptosis
-
Abbate A, Bussani R, Amin MS, Vetrovec GW, Baldi A. Acute myocardial infarction and heart failure: role of apoptosis. Int J Biochem Cell Biol. 2006;38:1834-1840.
-
(2006)
Int J Biochem Cell Biol
, vol.38
, pp. 1834-1840
-
-
Abbate, A.1
Bussani, R.2
Amin, M.S.3
Vetrovec, G.W.4
Baldi, A.5
-
26
-
-
0042917638
-
COMMA Investigators. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial
-
Granger CB, Mahaffey KW, Weaver WD, Theroux P, Hochman JS, Filloon TG, Rollins S, Todaro TG, Nicolau JC, Ruzyllo W, Armstrong PW; COMMA Investigators. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation. 2003;108:1184-1190.
-
(2003)
Circulation
, vol.108
, pp. 1184-1190
-
-
Granger, C.B.1
Mahaffey, K.W.2
Weaver, W.D.3
Theroux, P.4
Hochman, J.S.5
Filloon, T.G.6
Rollins, S.7
Todaro, T.G.8
Nicolau, J.C.9
Ruzyllo, W.10
Armstrong, P.W.11
-
27
-
-
0041732120
-
COMPLY Investigators. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial
-
Mahaffey KW, Granger CB, Nicolau JC, Ruzyllo W, Weaver WD, Theroux P, Hochman JS, Filloon TG, Mojcik CF, Todaro TG, Armstrong PW; COMPLY Investigators. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial. Circulation. 2003;108:1176-1783.
-
(2003)
Circulation
, vol.108
, pp. 1176-1783
-
-
Mahaffey, K.W.1
Granger, C.B.2
Nicolau, J.C.3
Ruzyllo, W.4
Weaver, W.D.5
Theroux, P.6
Hochman, J.S.7
Filloon, T.G.8
Mojcik, C.F.9
Todaro, T.G.10
Armstrong, P.W.11
-
28
-
-
0035808003
-
-
Baran KW, Nguyen M, McKendall GR, Lambrew CT, Dykstra G, Palmeri ST, Gibbons RJ, Borzak S, Sobel BE, Gourlay SG, Rundle AC, Gibson CM, Barron HV; Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study Group. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation. 2001;104:2778-2783.
-
Baran KW, Nguyen M, McKendall GR, Lambrew CT, Dykstra G, Palmeri ST, Gibbons RJ, Borzak S, Sobel BE, Gourlay SG, Rundle AC, Gibson CM, Barron HV; Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study Group. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation. 2001;104:2778-2783.
-
-
-
-
29
-
-
0037010009
-
The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: The results of the HALT-MI study
-
Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol. 2002;40:1199-1204.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 1199-1204
-
-
Faxon, D.P.1
Gibbons, R.J.2
Chronos, N.A.3
Gurbel, P.A.4
Sheehan, F.5
-
30
-
-
11144355760
-
Targeted anticytokine therapy in patients with chronic heart failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
-
Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004;109:1594-602.
-
(2004)
Circulation
, vol.109
, pp. 1594-1602
-
-
Mann, D.L.1
McMurray, J.J.2
Packer, M.3
Swedberg, K.4
Borer, J.S.5
Colucci, W.S.6
Djian, J.7
Drexler, H.8
Feldman, A.9
Kober, L.10
Krum, H.11
Liu, P.12
Nieminen, M.13
Tavazzi, L.14
van Veldhuisen, D.J.15
Waldenstrom, A.16
Warren, M.17
Westheim, A.18
Zannad, F.19
Fleming, T.20
more..
-
31
-
-
35848951385
-
Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling
-
Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang X-F, Frangogiannis NG. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation. 2007;116:2127-2138.
-
(2007)
Circulation
, vol.116
, pp. 2127-2138
-
-
Bujak, M.1
Ren, G.2
Kweon, H.J.3
Dobaczewski, M.4
Reddy, A.5
Taffet, G.6
Wang, X.-F.7
Frangogiannis, N.G.8
|